Evaluation of milk production and some blood parameters in lactating autochthonous goat extensively reared in Molise region

The trial, lasted 7 months and was performed on 60 lactating autochthonous goat populations (Montefalcone and Valfortorina) extensively reared in Molise Region. Goat milk yield and composition, and pasture chemical and floristic composition were recorded monthly. At the beginning (30d), at half (105d) and at the end (210d) of trial body weight and body condition score (BCS) were recorded; besides jugular blood samples were taken at 30, 105 e 210 d to determined the following parameters: glucose, total protein, albumin, urea, triglycerides, total and HDL cholesterol, NEFA, calcium, magnesium, sodium and potassium. The two populations showed a milk yield of 275 kg e 258 kg (Montefalcone e Valfortorina goat, respectively) throughout 180 days of lactation, which was similar or higher than mean milk yield of other goat breeds (Sarda, Ionica, Argentata dell'Etna). BCS increased significantly (P<0.01) during lactation in both populations. Blood parameters displayed significant changes (P<0.01) during the trial in Montefalcone goat for glucose, albumin, urea, triglycerides, total and HDL cholesterol, NEFA, sodium and potassium instead Valfortorina goat showed significant differences in total protein, urea, total and HDL cholesterol, NEFA, magnesium, sodium (P<0.01) and albumin and potassium (P<0.05). In both population, milk yield and quality showed promising results for autochthonous goats preservation

Dietary integration with natural extract in rabbit: Effects on growth performances and meat quality

In many countries of Europe rabbit meat is consumed for its nutritional characteristics, (Dalle Zotte, 2014; Hern\ue1ndez and Gondret, 2006). Since the ban of the use of antibiotic as growth promoter, natural substances have been studied as alternative with antioxidant, anti-inflammatory, antimicrobic and antiviral properties. The aim was to evaluate the effect of a dietary supplementation with natural extract mixture in growing rabbit on growth performances, carcass characteristics and Longissimus lumborum (LL) muscle parameters. The trial was performed at the Research Institute for Animal Production (Nitra, Slovak Republic) and lasted 42 days. At 35 days of age, 144 New Zealand White rabbits were randomly selected and divided in 3 experimental groups (4 rabbits/cage). The first fed a basal diet, the second (T1) and the third one (T2) received 0.3% and 0.6% of natural extract mixture, containing polyphenols from plants and seaweeds. Dietary integration with natural extract improve (P<0.05) growth performances (ADG, FI and FC) in T1 group. The fatty acid composition of LL muscle was positively affected (P=0.037) by natural extract supplementation with an increase of n-3 FA in T2 group than other treatments. Cholesterol content tended to be lower in T2 group (P=0.082) than T1 and C group (24.8 mg/100g T2 vs 34.6 mg/100g T1 vs 33.2 mg/100g C). Sensory analysis revealed that only the aroma was affected (P<0.05) by dietary treatments. Overall these results highlight that dietary supplementation with natural extract mixture, containing polyphenols from plants and seaweeds enhance growth performances, carcass weight, improving LL muscle nutritional parameters

Coexistence of an imbalance of cytokines, chemokines and growth factors serum levels and symptoms of fatigue and pain in long-term breast cancer survivors.

Background: Fatigue, pain and depression are common problems among long-term cancer survivors (BCS) which in some patients may persist for many years after healing and the completion of treatment. Several studies have reported that increased serum levels of chemokines and growth factors are particularly significantly correlated with the coexistence of these disorders in cancer survivors. The aim of this study was to assess whether the altered imbalance of pro-inflammatory cytokines, growth factors and chemokine serum levels are associated to presence of fatigue and pain in long-term breast cancer survivors . Methods: Ninety-three BCS were enrolled in this study and blood samples taken from each. Serum levels of 25 analytes including cytokines, growth factors and chemokines were tested by enzyme immunoassay using the flexible Bio-Plex System. Participants also completed a questionnaire measuring demographic, clinical and behavioral variables. Results: Non-parametric discriminant analysis showed that fatigued BCS had significantly higher serum levels of FGF and lower IL-4 and IL-8 compared to the non-fatigued group, while BCS with pain had an increase in eotaxin serum levels and lower IL-4 and Il-7 compared to the group without pain. Univariate analysis showed a statistically significant difference in both mental and physical qol, with levels lower in the subgroup who presented pain than in those without: p = 0.0003 and p < 0.0001 respectively. A lower value of Rantes (p = 0.0131) in breast cancer survivors with pain compared to the group without pain, and a higher median value of TNF-α (p = 0.054) in the pain group than in those without pain was observed. The level of depression was higher than the score of 50 on the Zung scale in fatigued survivors compared to non-fatigued survivors (p = 0.0006). Conclusions: Our results suggest that an altered balance of chemokines, cytokines and growth factors serum levels may be associated to presence of symptoms such as fatigue and pain in breast cancer survivors at an average of 5 years after diagnosis

Development of a novel monoclonal antibody with reactivity to a wide range of Venezuelan equine encephalitis virus strains

<p>Abstract</p> <p>Background</p> <p>There is currently a requirement for antiviral therapies capable of protecting against infection with Venezuelan equine encephalitis virus (VEEV), as a licensed vaccine is not available for general human use. Monoclonal antibodies are increasingly being developed as therapeutics and are potential treatments for VEEV as they have been shown to be protective in the mouse model of disease. However, to be truly effective, the antibody should recognise multiple strains of VEEV and broadly reactive monoclonal antibodies are rarely and only coincidentally isolated using classical hybridoma technology.</p> <p>Results</p> <p>In this work, methods were developed to reliably derive broadly reactive murine antibodies. A phage library was created that expressed single chain variable fragments (scFv) isolated from mice immunised with multiple strains of VEEV. A broadly reactive scFv was identified and incorporated into a murine IgG2a framework. This novel antibody retained the broad reactivity exhibited by the scFv but did not possess virus neutralising activity. However, the antibody was still able to protect mice against VEEV disease induced by strain TrD when administered 24 h prior to challenge.</p> <p>Conclusion</p> <p>A monoclonal antibody possessing reactivity to a wide range of VEEV strains may be of benefit as a generic antiviral therapy. However, humanisation of the murine antibody will be required before it can be tested in humans.</p> <p>Crown Copyright © 2009</p

Regulatory domain selectivity in the cell-type specific PKN-dependence of cell migration

The mammalian protein kinase N (PKN) family of Serine/Threonine kinases comprises three isoforms, which are targets for Rho family GTPases. Small GTPases are major regulators of the cellular cytoskeleton, generating interest in the role(s) of specific PKN isoforms in processes such as cell migration and invasion. It has been reported that PKN3 is required for prostate tumour cell invasion but not PKN1 or 2. Here we employ a cell model, the 5637 bladder tumour cell line where PKN2 is relatively highly expressed, to assess the potential redundancy of these isoforms in migratory responses. It is established that PKN2 has a critical role in the migration and invasion of these cells. Furthermore, using a PKN wild-type and chimera rescue strategy, it is shown that PKN isoforms are not simply redundant in supporting migration, but appear to be linked through isoform specific regulatory domain properties to selective upstream signals. It is concluded that intervention in PKNs may need to be directed at multiple isoforms to be effective in different cell types

Normal tissue toxicity after small field hypofractionated stereotactic body radiation

Stereotactic body radiation (SBRT) is an emerging tool in radiation oncology in which the targeting accuracy is improved via the detection and processing of a three-dimensional coordinate system that is aligned to the target. With improved targeting accuracy, SBRT allows for the minimization of normal tissue volume exposed to high radiation dose as well as the escalation of fractional dose delivery. The goal of SBRT is to minimize toxicity while maximizing tumor control. This review will discuss the basic principles of SBRT, the radiobiology of hypofractionated radiation and the outcome from published clinical trials of SBRT, with a focus on late toxicity after SBRT. While clinical data has shown SBRT to be safe in most circumstances, more data is needed to refine the ideal dose-volume metrics